Tatva Chintan Pharma Chem Limited (NSE: TATVA), ISIN INE0GK401011 — earnings, PEAD surprise, concall summary, Walk-the-Talk management consistency, SAST and insider filings, and the EquiSense Score (ECS), all in plain English on EquiSense.
TATVA last traded at ₹1713.00 (-1.67%), with a 52-week range of ₹977.85 to ₹1832.80 (as of 30 Jul 2026).
Shareholding as of Jun 2026: promoters 72.02%, FIIs 3.93%, DIIs 3.11%, mutual funds 2.79%.
EquiSense Score (ECS): 90/100.
Data sourced from NSE and BSE filings. Educational — not investment advice.